Appointment of Dr Muhunthan Thillai to Nuformix Scientific Advisory Board

Cambridge, UK - 6th September 2019

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs today announced that it has appointed Dr Muhunthan Thillai to Nuformix’s Scientific Advisory Board.

Download News

Back to all News